Mechanisms and consequences of fibrosis in systemic sclerosis.
about
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cellsOxidative damage and antioxidative therapy in systemic sclerosisProteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.Complementary and alternative medicine use was associated with higher perceived physical and mental functioning in early systemic sclerosis.Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicinePressure and pain in systemic sclerosis/scleroderma--an evaluation of a simple intervention (PISCES): randomised controlled trial protocolEffect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy.Systemic sclerosis-dermatological aspects. Part 1: Pathogenesis, epidemiology, clinical findings.Systemic sclerosis and silicone breast implant: a case report and review of the literature.Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon.Thrombospondin 1 is a key mediator of transforming growth factor β-mediated cell contractility in systemic sclerosis via a mitogen-activated protein kinase kinase (MEK)/extracellular signal-regulated kinase (ERK)-dependent mechanism.Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma?Plasma endogenous enkephalin levels in early systemic sclerosis: clinical and laboratory associations.Histopathological cutaneous alterations in systemic sclerosis: a clinicopathological studySystemic sclerosis: a prototypic multisystem fibrotic disorder.Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13Involvement of collagen-binding heat shock protein 47 in scleroderma-associated fibrosis.Interspecies comparison of human and murine scleroderma reveals IL-13 and CCL2 as disease subset-specific targetsHow does endothelial cell injury start? The role of endothelin in systemic sclerosis.Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactionsTherapeutic targets in systemic sclerosis.Circulating tissue inhibitor of matrix metalloproteinase-4 (TIMP-4) in systemic sclerosis patients with elevated pulmonary arterial pressure.Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis.Pro- and anti-fibrotic effects of TGF-beta in scleroderma.Caveolin-1, transforming growth factor-beta receptor internalization, and the pathogenesis of systemic sclerosis.New directions for patient-centred care in scleroderma: the Scleroderma Patient-centred Intervention Network (SPIN).Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.Possible strategies for anti-fibrotic drug intervention in scleroderma.Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.Update on etiopathogenesis of systemic sclerosis.Distinguishing between limited systemic scleroderma-associated pseudo-obstruction and peritoneal disseminationDiagnosis and Management of Systemic Sclerosis: A Practical Approach.Modulation of fibrosis in systemic sclerosis by nitric oxide and antioxidants.Emerging drugs and therapeutics for systemic sclerosis.Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective.Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.Proteinase activated receptor-2 counterbalances the vascular effects of endothelin-1 in fibrotic tight-skin mice.Living with scleroderma: patients' perspectives, a phenomenological study.
P2860
Q26851971-8E5EA0BE-8FA0-47A7-92B1-C39CCC8A3D04Q28394733-0EC79350-1021-41D2-BDA7-11DD135BE64DQ33665990-26AC3B3D-5513-4E39-84C0-884A8637CF74Q33874256-6B0F0FBB-7343-4100-A3D0-202DEBA7205AQ33945954-989AF999-34FE-4C2F-ABDC-5C3282C9899DQ34152046-1E4BE927-12E3-4C8C-9FCD-1CBE737569CEQ34207734-7057DA8C-B3CF-4050-BB63-F06BC94E5AE9Q34295337-107D8A7C-CCDF-4D51-BB84-8714A4076512Q34348470-9943BE8E-BCA4-4C6E-AB01-814BE2BD1508Q34485231-51A50020-8B6C-4515-9E29-7BA6ECAD7A58Q34698456-B45C2C7E-4FEE-4DEA-99C4-5A144A5AA40CQ34797834-26AC0FAC-B51D-4720-B3E9-FE081175D533Q35072458-CF315A48-EB61-427C-96E7-25C2D0A2D09AQ35329551-9D2F239F-2E63-4BAE-8357-6651E1E3E786Q35620376-CB34B51A-F9DF-4D62-8136-4D47721AF487Q35649427-589D8FF9-41E4-441F-8CCA-D22BFA0708B3Q35669762-8F27ECCE-1621-4629-B8D5-6E2A1F293F89Q35862865-F5D4E8B2-42A6-4CCD-AB74-234A30F245B5Q35952040-22571CE2-827B-4D14-8E21-6649495979CAQ36927745-7B60627F-2735-4303-BCFB-046E96BBA4E1Q36927753-6750B859-25EB-4224-B12D-5B3E11E0D604Q36927761-9DE0639C-5F24-4DCF-AFE0-CA2848EE7338Q37071471-87CF3513-C324-4F72-B191-04FBF9D01518Q37224668-608B041E-FE17-49A4-A9BB-82314598B36CQ37265853-40E361F2-50F5-4262-82A9-87A2CCD4D048Q37307795-C4EC31D6-7D5B-4FD3-B214-4A025CFDDF17Q37586400-AA90E48D-03F3-4E30-BDDC-FE4138A5A050Q37638268-2885F858-C920-47CA-BE97-FEE15C67702CQ37689681-FD3A8903-A622-4972-A961-D14FD3F6F752Q37864123-EDBB269A-9FD9-4066-97B1-285B2E2EF6E5Q37959313-9C05A25A-C4D4-406B-9454-341BC8510AA3Q38183300-C499C37C-3E10-4D22-AF49-093379F39582Q38326760-34A3080B-4F04-4966-A728-44E9C28F363EQ38667111-0CDE2AB5-D5EE-41EF-9738-07EBA4BDD722Q38909892-021101F4-7554-4B2F-99CA-4A2136776E50Q38998611-A4DB87A1-90A4-4FD0-83E8-062130E364D2Q39063947-14D2C5DB-2A69-49FB-B584-656C243B15A1Q39129418-1FF6A9B0-1BFE-4BD0-875A-7AF38B415028Q39393743-DE33099E-FB8F-4710-B3A0-093AE97CA81AQ39686272-07840577-24D9-4EC4-8659-CF7DB5D3E3F3
P2860
Mechanisms and consequences of fibrosis in systemic sclerosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanisms and consequences of fibrosis in systemic sclerosis.
@ast
Mechanisms and consequences of fibrosis in systemic sclerosis.
@en
type
label
Mechanisms and consequences of fibrosis in systemic sclerosis.
@ast
Mechanisms and consequences of fibrosis in systemic sclerosis.
@en
prefLabel
Mechanisms and consequences of fibrosis in systemic sclerosis.
@ast
Mechanisms and consequences of fibrosis in systemic sclerosis.
@en
P2093
P356
P1476
Mechanisms and consequences of fibrosis in systemic sclerosis.
@en
P2093
Carol M Black
Christopher P Denton
David J Abraham
P2860
P304
P356
10.1038/NCPRHEUM0115
P577
2006-03-01T00:00:00Z